Our finding that loss of immune tolerance in myeloid S100A4+ DCs can mediate mAIP in mice may help to explain some pathogenic aspects of human AIP, an IgG4-related sclerosing disease. The gene discussed is S100A4; the disease is autoimmune pancreatitis.